SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001171843-22-002609
Filing Date
2022-04-15
Accepted
2022-04-15 16:33:33
Documents
12
Period of Report
2022-04-12
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 FORM 8-K f8k_041522.htm   iXBRL 8-K 20330
  Complete submission text file 0001171843-22-002609.txt   190644

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE cytk-20220412.xsd EX-101.SCH 3045
3 XBRL LABEL FILE cytk-20220412_lab.xml EX-101.LAB 34476
4 XBRL PRESENTATION FILE cytk-20220412_pre.xml EX-101.PRE 22603
6 EXTRACTED XBRL INSTANCE DOCUMENT f8k_041522_htm.xml XML 3498
Mailing Address 350 OYSTER POINT BOULEVARD SOUTH SAN FRANCISCO CA 94080
Business Address 350 OYSTER POINT BOULEVARD . SOUTH SAN FRANCISCO CA 94080 (650) 624-3000
CYTOKINETICS INC (Filer) CIK: 0001061983 (see all company filings)

IRS No.: 943291317 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-50633 | Film No.: 22830358
SIC: 2834 Pharmaceutical Preparations